Access to anti-retroviral drugs, female in Mauritania
Mauritania: Access to anti-retroviral drugs, female was 68.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Mauritania, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Mauritania stood at 68.0%. That is the highest value across all 25 years on record.
The figure is up 6.2% on the previous year and up 106.1% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Mauritania peaked at 68.0% in 2024 and was at its lowest, 0.0%, in 2000.
Mauritania ranks 86th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Mauritania, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 1.0% | — |
| 2005 | 3.0% | +200.0% |
| 2006 | 7.0% | +133.3% |
| 2007 | 11.0% | +57.1% |
| 2008 | 15.0% | +36.4% |
| 2009 | 19.0% | +26.7% |
| 2010 | 22.0% | +15.8% |
| 2011 | 22.0% | +0.0% |
| 2012 | 26.0% | +18.2% |
| 2013 | 31.0% | +19.2% |
| 2014 | 33.0% | +6.5% |
| 2015 | 36.0% | +9.1% |
| 2016 | 38.0% | +5.6% |
| 2017 | 48.0% | +26.3% |
| 2018 | 48.0% | +0.0% |
| 2019 | 53.0% | +10.4% |
| 2020 | 54.0% | +1.9% |
| 2021 | 56.0% | +3.7% |
| 2022 | 60.0% | +7.1% |
| 2023 | 64.0% | +6.7% |
| 2024 | 68.0% | +6.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.6% | 0.0% | 19.0% | 10 |
| 2010s | 35.7% | 22.0% | 53.0% | 10 |
| 2020s | 60.4% | 54.0% | 68.0% | 5 |
Countries ranked near Mauritania
More gender data for Mauritania
- Child population (UN estimates and projections) 2,466 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 1.77 % change on previous year (2030)
- Population 3,596 (2030)
- Working-age population (UN estimates and projections) 3,596 (2030)
- Population (UN estimates and projections), annual growth rate 3.17 % change on previous year (2030)
- Age population, age 00, female, interpolated 85,317 (2025)
- Age population, age 00, male, interpolated 87,574 (2025)
- Age population, age 01, female, interpolated 83,378 (2025)
- Age population, age 01, male, interpolated 85,511 (2025)
- Age population, age 02, female, interpolated 81,699 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Mauritania?
- Access to anti-retroviral drugs, female in Mauritania was 68.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Mauritania?
- The highest recorded value was 68.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Mauritania?
- The lowest recorded value was 0.0% in 2000.
- How does Mauritania rank for access to anti-retroviral drugs, female?
- Mauritania ranks 86th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Mauritania?
- Over the last ten years it is up 106.1%. The long-run trend across the full record is volatile.
- Where does this Mauritania data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.